Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Abstract
Muscarinic acetylcholine receptors (mAChRs), M(1)-M(5), regulate the activity of numerous fundamental central and peripheral functions. The lack of small-molecule ligands that can block or activate specific mAChR subtypes with high selectivity has remained a major obstacle in defining the roles of the individual receptor subtypes and in the development of novel muscarinic drugs. Recently, phenotypic analysis of mutant mouse strains deficient in each of the five mAChR subtypes has led to a wealth of new information regarding the physiological roles of the individual receptor subtypes. Importantly, these studies have identified specific mAChR-regulated pathways as potentially novel targets for the treatment of various important disorders including Alzheimer's disease, schizophrenia, pain, obesity and diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Gq/11-coupled M1, M3 and M5 mAChRs elicit Ca2+ release from the endoplasmic reticulum (ER) by activating the downstream phospholipase C/inositol 1,4,5-trisphosphate/inositol 1,4,5-trisphosphate receptor (PLC/IP3/IP3R) cascade49, the same pathway triggered by TCR signaling.”
From Tumor-specific cholinergic CD4+ T lymphocytes guide immunosurveillance of hepatocellular carcinoma (2023) · cites this paper as [49]
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
The role of acetylcholine in learning and memory
Hasselmo, M. E. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.09.002 · Cited by 1,693 · cited 1×
“Alzheimer's disease and cognitive impairments A convincing body of data indicate that mAChRs have central roles in facilitating cognitive function”
BackgroundInternational Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors
Caulfield, M. P., & Birdsall, N. J. M. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01362-0 · Cited by 1,474
Muscarinic Receptors—Characterization, coupling and function
Caulfield, M. P. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90027-b · Cited by 1,277
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072
Koob, G. F., Sanna, P. P., & Bloom, F. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80557-7 · Cited by 1,026
The current status of the dopamine hypothesis of schizophrenia
CARLSSON, A. (1988) · Neuropsychopharmacology · doi:10.1016/0893-133x(88)90012-7 · Cited by 958
Autonomic regulation of islet hormone secretion - Implications for health and disease
Ahrén, B. (2000) · Diabetologia · doi:10.1007/s001250051322 · Cited by 909
Cited by
Items 601–671 of 671
In-Silico Anti-Diarrhoeal Evaluation of Lagu Gangathara Chooranam
Anandhalakshmi, D., Pavithra, A., Surya, A., Nalini Sofia, H., Vetha Merlin Kumari, H., Kantham, T. L., & Meenakumari, R. (2024) · International Journal of Ayurvedic Medicine · doi:10.47552/ijam.v14i4.3906
Kitazawa, T., Teraoka, H., Harada, N., Ochi, K., Nakamura, T., Asakawa, K., KANEGAE, S., Yaosaka, N., Unno, T., Komori, S., et al. (2024) · Neuromethods · doi:10.1007/978-1-0716-4015-9_14
Ertürk, Z. K., Özçelebi, E., Göçmen, A. Y., Doğanyiğit, Z., Okan, A., & İskit, A. B. (2024) · Research Square · doi:10.21203/rs.3.rs-4618612/v1
A case report on antimuscarinic drug-induced confusion: A cognitive side effect
-, B. M. V., George, A., James, E., & -, R. E. R. (2024) · National Journal of Pharmacology and Therapeutics · doi:10.4103/njpt.njpt_26_24
Malta, A., Matiusso, C. C. I., de Lima, L. D. S., Ribeiro, T. A., Tófolo, L. P., Almeida, D. L., Moreira, V. M., Martins, I. P., Pavanello, A., & Mathias, P. C. D. F. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00191.2024
Brain distribution and muscarinic receptor occupancy of an active metabolite of fesoterodine in rats
Shiho, M., Tanaka, S., Nakatani, E., Kurosawa, T., Kubo, Y., Deguchi, Y., & Okura, T. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2024.100058 · Cited by 1
Wang, J., Niu, X., Jin, C., & Hu, Y. (2025) · Biomolecular NMR Assignments · doi:10.1007/s12104-025-10230-9
Meister, J., Wanka, L., Perry, N. A., Liu, L., Iverson, T. M., Gurevich, V. V., Beck‐Sickinger, A. G., Kruse, A. C., & Wess, J. (2025) · Biochemistry · doi:10.1021/acs.biochem.5c00036
Self-citationEspañol, A. J., Sánchez, Y., & Volpi, S. (2025) · Biocell · doi:10.32604/biocell.2025.068034 · Cited by 1
Muscarinic Acetylcholine Receptor Activators as Transformative Therapeutics for Schizophrenia
Conn, P. J., & Paul, S. M. (2025) · Annual Review of Medicine · doi:10.1146/annurev-med-042123-021759
Cholinergic contributions to Parkinsonian symptoms and l-DOPA-induced dyskinesia
Tubert, C., Paz, R. M., Stahl, A. M., & Murer, M. G. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-21992-4.00008-7 · Cited by 1
Gregro, A. R., Park, C., Long, M. F., Baker, L. A., Bollinger, K. A., Ringuette, A. E., Peng, L., Luscombe, V. B., Billard, N. B., Rodriguez, A. L., et al. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00963
Doura, T., Kakegawa, W., Morikawa, K., Yamasaki, T., Tran, D. P., Fujinaga, M., Kondo, T., Kashiwa, S., Hasegawa, K., Miura, E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.23.707339
Design and Synthesis of Dualsteric Muscarinic M5 Receptor Ligands Reveal G Protein Bias
Steinmüller, S. A. M., Flake, A., Bermúdez, M., Ashdown, P. T., Hislop, J. N., & Decker, M. W. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00039
The central cholinergic system as a therapeutic target in Parkinson's disease
Miller, S. J., Yue, J., Bozal, S. B., Logan, R. A., & Hafler, B. P. (2026) · Journal of Parkinson s Disease · doi:10.1177/1877718x261427270 · Cited by 1
Medjber, K. (2012) · theses.fr (ABES) · doi:10.70675/67af7715z8123z41dfz8bb4zf3803999338e · Cited by 2
Neuromodulation in the Olfactory Bulb
Smith, R. E. (2015) · theses.fr (ABES) · doi:10.70675/a431d14fz588cz4bdcz8e0ezd4f43eba4e60 · Cited by 1
Soualeh, N. (2017) · theses.fr (ABES) · doi:10.70675/035f2418z4137z4706zb59az81d97410d751
de Fondaumière, M. (2023) · theses.fr (ABES) · doi:10.70675/9dc73a0az2db9z4547zb5b3z6d65b7b632bc
Multi‐Omics Reveals Dysregulated Neurotransmitter Systems in Aging and CNS Disorders
Niu, R.-Z., Zhang, M., Li, Y., Zhou, X., Liu, X. J., Wu, J., Wang, W. Q., Wang, Y., Ruan, Y., Ding, Y., et al. (2026) · Aging Cell · doi:10.1111/acel.70544
Liu, M., Chen, Y., Tian, L., Zhou, H., Zhou, H., & Liu, Q. (2026) · Chinese Journal of Organic Chemistry · doi:10.6023/cjoc202510015
Muramatsu, I., Uwada, J., Nagai‐Arakawa, I., Matsukawa, N., & Masuoka, T. (2026) · FEBS Letters · doi:10.1002/1873-3468.70385
Gill, S. K., Chahal, S., Sarkar, S. S., Yadava, T., Sindhu, J., & Acharya, B. N. (2026) · Molecular Diversity · doi:10.1007/s11030-026-11619-x
Acetylcholine Receptor Structure
Li, H., & Hibbs, R. E. (2026) · Current clinical neurology · doi:10.1007/978-3-032-19140-3_2
Pyrazolo[3,4-b]pyridine: a privileged scaffold for the synthesis of anti-Alzheimer’s agents
Waly, O. M., El‐Sayed, S. M., Ghaly, M. A., & El‐Subbagh, H. I. (2026) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-026-01006-6
Gross, S., Koch, P., & Straßer, A. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00587
Ji, F., Ma, L., Shen, X., Liang, X., Cui, W., Zhou, Y., Wang, X.-E., & Liu, H. (2026) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253261478086
Zhou, C., Zhu, C., Wang, X., Yang, Y., & Wei, J. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179275
Development of covalent agonists for the muscarinic acetylcholine receptor
Eitel, K., Risel, P., Kaindl, J. M., Einsiedel, J., Hübner, H., & Gmeiner, P. (2026) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2026.118783
Glycoalkaloids Affect the Animal Nervous System: A Review
Dudek, G., Jaworska, A., & Marciniak, P. (2026) · Journal of Toxicology · doi:10.1155/jt/1380303
BindingDB Entry 50042945: Discovery of ML326: The first sub-micromolar, selective M5 PAM.
BindingDB (2014) · UC San Diego · doi:10.7270/q2h41st9
BindingDB Entry 50032923: FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors.
BindingDB (2011) · UC San Diego · doi:10.7270/q2sf2wfk
BindingDB (2014) · UC San Diego · doi:10.7270/q2g44rs8
BindingDB (2016) · UC San Diego · doi:10.7270/q2hd7x8t
BindingDB Entry 50014554: Discovery of VU6028418: A Highly Selective and Orally Bioavailable M
BindingDB (2022) · UC San Diego · doi:10.7270/q22b92v4
BindingDB (2013) · UC San Diego · doi:10.7270/q2n29z8s
BindingDB Entry 50011576: The optimization of a novel selective antagonist for human M
BindingDB (2022) · UC San Diego · doi:10.7270/q2862m3q
BindingDB Entry 50038449: Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.
BindingDB (2012) · UC San Diego · doi:10.7270/q2mk6dsm
BindingDB (2021) · UC San Diego · doi:10.7270/q2pr8081
Patowary, S. (2013) · UWM Digital Commons (University of Wisconsin–Milwaukee)
Metadata
- Authors
- Wess, J., Eglen, R. M., & Gautam, D.
- Affiliations
- National Institutes of Health (US)
- PerkinElmer (United States) (US)
- Corresponding author
- Wess, Jürgen
- ORCID
- Wess, Jürgen
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-09
- Volume
- 6
- Issue
- 9
- Pages
- 721-733
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1999774383
- Cited by
- 637
- References
- 134
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 29 · 2023: 33 · 2022: 21 · 2021: 25 · 2020: 23 · 2019: 29 · 2018: 36 · 2017: 32 · 2016: 38 · 2015: 26 · 2014: 45 · 2013: 40 · 2012: 43
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- muscarinic receptors, knockout mice, Alzheimer's disease, schizophrenia, pain, obesity, diabetes mellitus, receptor function
- MeSH terms
- Animals, Disease Models, Animal, Ligands, Receptors, Muscarinic, Drug Design, Mice, Knockout, Muscarinic Agonists, Muscarinic Antagonists, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.